LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 26th Prioritisation – 1st quarter 2016

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 26th Prioritisation – 1st quarter 2016. HSO: 26th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
420Kb
Abstract

For the 26th prioritisation (March 2016), 12 drugs were filtered out of 224 identified and were sent to prioritisation. Of these, 2 drugs were ranked as "highly relevant" by the expert panel, 9 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 26th Prioritisation
Deposited on:22 Apr 2016 12:32
Last Modified:05 Aug 2016 19:44

Repository Staff Only: item control page